Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation

Cardiology (Switzerland)

Volumn 124, Issue 1, 2013, Pages 3-10

  Providência, Rui ^a,b   Fernandes, Andreia ^a   Paiva, Luís ^a   Faustino, Ana ^a   Barra, Sérgio ^a   Botelho, Ana ^a   Trigo, Joana ^a   Nascimento, José ^a   Leitão Marques, António ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Atrial fibrillation; Chronic kidney disease; Chronic Kidney Disease Epidemiology Collaboration equation; Estimated glomerular filtration rate; Stroke

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; DENSE SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; HYPERTENSION; LEFT ATRIAL APPENDAGE THROMBUS; LEFT ATRIAL STASIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR DISEASE; ARTERY DISEASE; DISEASE MARKER; FLOW RATE; PREDICTIVE VALUE; SCORING SYSTEM;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; GLOMERULAR FILTRATION RATE; HEART ATRIA; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; STROKE; STROKE VOLUME; THROMBOEMBOLISM;

EID: 84871213726     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000345434     Document Type: Article

References (33)

1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991; 22: 983-988
2. Heeringa J, Van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BH, et al: Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006; 27: 949-953
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al: Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375
4. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125 (erratum published in Circulation 2006; 114:e498
5. Authors/Task Force Members, Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, et al: 2010 focused update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy- developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010; 31: 2677-2687
6. Pelisek J, Hahntow IN, Eckstein HH, Ockert S, Reeps C, Heider P, et al: Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg 2011; 54: 1643-1649
7. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation- Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 1998; 31: 1622-1626
8. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation-The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998; 128: 639-647
9. Bernhardt P, Schmidt H, Hammerstingl C, Lüderitz B, Omran H: Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 1807-1812
10. Badano LP, Pezzutto N, Marinigh R, Cinello M, Nucifora G, Pavoni D, et al: How many patients would be misclassified using Mmode and two-Dimensional estimates of left atrial size instead of left atrial volumëA three-Dimensional echocardiographic study. J Cardiovasc Med (Hagerstown) 2008; 9: 476-484
11. Russo C, Hahn RT, Jin Z, Homma S, Sacco RL, Di Tullio MR: Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-Dimensional echocardiography. J Am Soc Echocardiogr 2010; 23: 954-960
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al: Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108
14. Fatkin D, Kelly RP, Feneley MP: Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969
15. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331: 1474-1479
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
17. Shafi T, Matsushita K, Selvin E, Sang Y, Astor BC, Inker LA, Coresh J: Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: The third National Health and Nutrition Examination Survey (NHANES III). BMC Nephrol 2012; 13: 42
18. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S246
19. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Eng J Med 2004; 351: 1296-1305
20. Deftereos S, Giannopoulos G, Kossyvakis C, Raisakis K, Kaoukis A, Aggeli C, et al: Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset. Heart 2011; 97: 914-917
21. Providência R, Paiva L, Faustino A, Botelho A, Trigo J, Casalta-Lopes J, et al: Cardiac troponin I: Prothrombotic risk marker in nonvalvular atrial fibrillation. Int J Cardiol 2012, E-pub ahead of print
22. Ederhy S, Di Angelantonio E, Dufaitre G, Meuleman C, Masliah J, Boyer-Chatenet L, et al: C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation. Int J Cardiol 2011, E-pub ahead of print
23. Providência R, Botelho A, Trigo J, Quintal N, Nascimento J, Mota P, et al: Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Europace 2012; 14: 36-45
24. Yoshida M, Nakamura Y, Higashikawa M, Kinoshita M: Predictors of ischemic stroke in non-rheumatic atrial fibrillation. Int J Cardiol 1996; 56: 61-70
25. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, et al: A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 2003; 290: 1049-1056
26. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL, et al: Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. J Am Coll Cardiol 2000; 35: 183-187
27. Inoue H, Atarashi H, Research Group for Antiarrhythmic Drug Therapy: Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation. Am J Cardiol 2000; 86: 852-855
28. Chou CC, Lien LM, Chen WH, Wu MS, Lin SM, Chiu HC, et al: Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: A population-based study. Stroke 2011; 42: 2120-2125
29. Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I: Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population. Ann Med 2012, E-pub ahead of print
30. Bos MJ, Koudstaal PJ, Hofman A, Breteler MM: Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: The Rotterdam Study. Stroke 2007; 38: 3127-3132
31. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
32. Marinigh R, Lane DA, Lip GY: Severe renal impairment and stroke prevention in atrial fibrillation: Implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol 2011; 57: 1339-1348
33. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY: A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest 2010, E-pub ahead of print